| Identification |
| Name: | Pregn-4-ene-3,20-dione,11-hydroxy-17-(1-oxobutoxy)-21-(1-oxopropoxy)-, (11b)- |
| Synonyms: | 17a-Butyryloxy-11b-hydroxy-21-propionyloxy-4-pregnene-3,20-dione;Hydrocortisone 17-butyrate 21-propionate; Hydrocortisone buteprate;Hydrocortisone probutate; Pandel; TS 408 |
| CAS: | 72590-77-3 |
| EINECS: | 276-726-9 |
| Molecular Formula: | C28H40 O7 |
| Molecular Weight: | 488.68 |
| InChI: | InChI=1/C28H40O7/c1-5-7-24(33)35-28(22(31)16-34-23(32)6-2)13-11-20-19-9-8-17-14-18(29)10-12-26(17,3)25(19)21(30)15-27(20,28)4/h14,19-21,25,30H,5-13,15-16H2,1-4H3/t19-,20-,21-,25+,26-,27-,28-/m0/s1 |
| Molecular Structure: |
 |
| Properties |
| Flash Point: | 194.7°C |
| Boiling Point: | 608.9°C at 760 mmHg |
| Density: | 1.2g/cm3 |
| Refractive index: | 1.547 |
| Specification: | usageEng:A synthetic adrenocorticosteroid that acts as an anti-inflammatory and anti-pruritic agents. It is used as a topical for the treatment of dermatologic disorders such as atopic dermatitis and psoriasis. |
| Flash Point: | 194.7°C |
| Usage: | A synthetic adrenocorticosteroid that acts as an anti-inflammatory and anti-pruritic agents. It is used as a topical for the treatment of dermatologic disorders such as atopic dermatitis and psoriasis. |
| Safety Data |
| |
 |